Loading
Life sciences · Observational Study
ClinicalTrials.gov · September 25, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Observational Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07840807). This is a study registration, not published results. Lead sponsor: The Seventh Affiliated Hospital of Sun Yat-sen University. Recruitment status: COMPLETED. Study type: OBSERVATIONAL. Enrollment: 1149 participants (ACTUAL). Conditions: Obesity & Overweight, Diabete Type 2, Metabolic Syndrome. Interventions: OTHER: Traditional Chinese Medicine Fasting Therapy. Primary outcome measures: Correlation between changes in serum beta-hydroxybutyrate (βHB) and changes in metabolic indicators , Baseline and at completion of TCM fasting therapy, an average of 7 days; Correlation between increase in serum beta-hydroxybutyrate (βHB) and improvement in metabolic indicators , Baseline and post-intervention , an average of 7 days. Brief summary: This is a retrospective study using existing medical records. The purpose is to learn how Traditional Chinese Medicine (TCM) fasting therapy affects metabolism. The study also examines whether a substance called beta-hydroxybutyrate (βHB), which is produced during fasting, is related to improvements in metabolic health. The researchers will review records of patients who previously received TCM fasting therapy. Patients will be divided into three groups based on how much their βHB levels increased after therapy (low, medium, and high). The study will compare changes in metabolic health measures, such as body weight, BMI, waist size, blood pressure, blood sugar, and blood fats, before and after therapy. It will also analyze whether greater increases in βHB are linked to greater improvements in these metabolic measures, while taking into account factors like age, sex, and baseline BMI. This study does not involve any new tests or treatments. It only uses data that already exist in patient records. The findings may help doctors better understand how TCM fasting therapy works and whether βHB could be a useful marker for guiding treatment in the future.